✦ LIBER ✦

Increased AF1q gene expression in high-risk myelodysplastic syndrome

✍ Scribed by William Tse; H. Joachim Deeg; Derek Stirewalt; Frederick R. Appelbaum; Jerald Radich; Theodore Gooley

Book ID: 108672974
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 80 KB
Volume: 128
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2004.05306.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Survivin expression in “low-risk” and “h

Survivin expression in “low-risk” and “high-risk” myelodysplastic syndromes

✍ Umberto Gianelli; Nicola Stefano Fracchiolla; Agostino Cortelezzi; Caterina Pell 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 166 KB

Clinical significance of high-Km 5′-nucl

Clinical significance of high-Km 5′-nucleotidase (cN-II) mRNA expression in high-risk myelodysplastic syndrome

✍ Keijiro Suzuki; Takeshi Sugawara; Tatsuo Oyake; Toshiyuki Uchiyama; Yusei Aoki; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Abnormal expression of PACAP gene in pat

Abnormal expression of PACAP gene in patients with myelodysplastic syndrome

✍ Stella Aprilia Ika; Zixing Chen; Xiaofei Qi; Hongjie Shen; Jiannong Cen; Yuanyua 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 403 KB

Reduced expression of FLIPSHORT in bone

Reduced expression of FLIPSHORT in bone marrow of low risk myelodysplastic syndrome

✍ Paula de Melo Campos; Fabíola Traina; Adriana da Silva Santos Duarte; Irene Lora 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Apoptosis is dysregulated in patients with myelodysplastic syndrome (MDS) and acute myelogenous leukaemia (AML). FLIP (FLICE (FAS-associated death-domain-like IL-1 beta-converting enzyme)-inhibitory protein) has been described as an anti-apoptotic protein. Here, we characterize the expression level

High-dose chemotherapy in high-risk myel

High-dose chemotherapy in high-risk myelodysplastic syndrome : Covariate-adjusted comparison of five regimens

✍ Miloslav Beran; Yu Shen; Hagop Kantarjian; Susan O'Brien; Charles A. Koller; Fra 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB

Lenalidomide is active in Japanese patie

Lenalidomide is active in Japanese patients with symptomatic anemia in low- or intermediate-1 risk myelodysplastic syndromes with a deletion 5q abnormality

✍ Hironori Harada; Mitsumasa Watanabe; Kenshi Suzuki; Soshi Yanagita; Takahiro Suz 📂 Article 📅 2009 🏛 Carden Jennings Publishing 🌐 English ⚖ 228 KB